Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-30

Clinical Trial Update: Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets [Phase 2]

View source ↗

Summary

Phase 2 trial assessing effective doses, safety, and efficacy of Hypidone Hydrochloride Tablets for major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypidone Hydrochloride Tablets (Hypidone hydrochloride)

Snippet

Sponsor: Zhejiang Huahai Pharmaceutical Co., Ltd. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED